Related references
Note: Only part of the references are listed.The effect of smoking on pain-related evoked potentials
Takahiro Miyazaki et al.
BRAIN RESEARCH (2010)
Anti-TNF-alpha Agents Are Less Effective for the Treatment of Rheumatoid Arthritis in Current Smokers
A. Abhishek et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2010)
Remission achieved after 2 years treatment with low-dose prednisolone in addition to disease-modifying anti-rheumatic drugs in early rheumatoid arthritis is associated with reduced joint destruction still present after 4 years: an open 2-year continuation study
I. Hafstroem et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Determinants of Red Blood Cell Methotrexate Polyglutamate Concentrations in Rheumatoid Arthritis Patients Receiving Long-Term Methotrexate Treatment
Lisa K. Stamp et al.
ARTHRITIS AND RHEUMATISM (2009)
Relationship Between Pack-year History of Smoking and Response to Tumor Necrosis Factor Antagonists in Patients with Rheumatoid Arthritis
Derek L. Mattey et al.
JOURNAL OF RHEUMATOLOGY (2009)
Rheumatoid arthritis patients who smoke have a higher need for DMARDs and feel worse, but they do not have more joint damage than non-smokers of the same serological group
G. Westhoff et al.
RHEUMATOLOGY (2008)
Strong combined gene-environment effects in anti-cyclic citrullinated peptide-positive rheumatoid arthritis - A nationwide case-control study in Denmark
Merete Pedersen et al.
ARTHRITIS AND RHEUMATISM (2007)
Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis
Henrik Kallberg et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Sex: a major predictor of remission in early rheumatoid arthritis?
K. Forslind et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
The PTPN22 1858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden
Heidi Kokkonen et al.
ARTHRITIS RESEARCH & THERAPY (2007)
Predictors of response to anti-TNF-α therapy among patients with rheumatoid arthritis:: results from the British Society for Rheumatology Biologics Register
K. L. Hyrich et al.
RHEUMATOLOGY (2006)
Association of HLA-C3 and smoking with vasculitis in patients with rheumatoid arthritis
Carl Turesson et al.
ARTHRITIS AND RHEUMATISM (2006)
The effects of tobacco smoking and rheumatoid factor seropositivity on disease activity and joint damage in early rheumatoid arthritis
V. F. Manfredsdottir et al.
RHEUMATOLOGY (2006)
Smoking is a strong risk factor for rheumatoid nodules in early rheumatoid arthritis
BM Nyhäll-Wåhlin et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles
SP Linn-Rasker et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides
Merete Pedersen et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate -: A two-year randomized trial
B Svensson et al.
ARTHRITIS AND RHEUMATISM (2005)
Prediction of radiological outcome in early rheumatoid arthritis in clinical practice:: role of antibodies to citrullinated peptides (anti-CCP)
K Forslind et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Share Paper
